Relation between GB virus C/hepatitis G virus and fulminant hepatic failure may be secondary to treatment with contaminated blood and/or blood products

Gut

Volumn 44, Issue 2, 1999, Pages 274-278

  Halasz, R ^a   Barkholt, L ^b   Lara, C ^a   Hultgren, C ^a   Ando, Y ^a   Broome U ^b   Fischler, B ^b   Nemeth, A ^b   Ericzon, B G ^b   Sonnerborg A ^a   Sallberg M ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

Antibodies; Fulminant hepatitis; GB virus C; Hepatitis G virus; Liver; RNA

Indexed keywords

VIRUS ANTIBODY; VIRUS RNA;

ADOLESCENT; ADULT; AGED; ANTIBODY DETECTION; ARTICLE; BLOOD TRANSFUSION; CHILD; ENZYME IMMUNOASSAY; HEPATITIS; HEPATITIS G VIRUS; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS DETECTION; VIRUS HEPATITIS;

EID: 0033027537     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.44.2.274     Document Type: Article

References (22)

1. Simons JN, Leary TP, Dawson GJ, et al. Isolation of novel virus-like sequences associated with human hepatitis. Nat Med 1995 1:564-9.
2. Linnen J, Wages J, Jr, Zhang-Keck ZY, et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 1996;271:505-8.
3. Yoshiba M, Okamoto H, Mishiro S. Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology. Lancet 1995;346:1131-2.
4. Kao JH, Chen PJ, Chen DS. GBV-C In the aetiology of fulminant hepatitis. Lancet 1996;347:120.
5. Moatter T, Tariq SA, Fisher-Hoch S, et al. Hepatitis G virus in Karachi, Pakistan. Lancet 1996;348:1318-19.
6. Tameda Y, Kosaka Y, Tagawa S, et al. Infection with GB virus C (GBV-C) in patients with fulminant hepatitis. J Hepatol 1996;25:842-7.
7. Heringlake S, Osterkamp S, Trautwein C, et al. Association between fulminant hepatic failure and a strain of GB virus C. Lancet 1996;348:1626-9.
8. Saiz JC, Sans M, Mas A, et al. Hepatitis G virus infection in fulminant hepatic failure. Gut 1997;41:696-9.
9. Haydon GH, Jarvis LM, Simpson KJ, et al. The clinical significance of the detection of hepatitis GBV-C RNA in the serum of patients with fulminant, presumed viral, hepatitis. J Viral Hepat 1997;4:45-9.
10. Moaven LD, Locarnini SA, Bowden DS, et al. Hepatitis G virus and fulminant hepatic failure: evidence for transfusion-related infection. J Hepatol 1997;27:613-19.
11. Kanda T, Yokosuka O, Ehata T, et al. Detection of GBV-C RNA in patients with non-A-E fulminant hepatitis by reverse-transcription polymerase chain reaction. Hepatology 1997;25:1261-5.
12. Muerhoff AS, Leary TP, Simons JN, et al. Genomic organization of GB viruses A and B: two new members of the Flaviviridae associated with GB agent hepatitis. J Virol 1995;69:5621-30.
13. Chen M, Sönnerborg A, Johansson B, et al. Detection of hepatitis G (or GB Virus C) RNA in human saliva. J Clin Microbiol 1997;35:973-5.
14. Fishler B, Lara C, Chen M, et al. Genetic evidence for mother-to-infant transmission of hepatitis G (GBV-C) virus. J Infect Dis 1997;176:281-5.
15. Madejon A, Fogeda M, Bartolome J, et al. GB virus C RNA in serum, liver, and peripheral blood mononuclear cells from patients with chronic hepatitis B, C, and D. Gastroenterology 1997;113:573-8.
16. Bralet MP, Roudotthoraval F, Pawlotsky JM, et al. Histopathologic impact of GB virus C infection on chronic hepatitis C. Gastroentology 1997;112:188-92.
17. Mishiro S, Yoshiba M, Okamoto H. GBV-C in the aetiology of fulminant hepatitis. Lancet 1996;347:120-1.
18. Nei M, Gojobori T. Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Mol Biol Evol 1986;3:418-26.
19. Pilotmatias TJ, Carrick RJ, Coleman PF, et al. Expression of the GB virus C E2 glycoprotein using the Semliki Forest virus vector system and its utility as a serologic marker. Virology 1996;225:282-92.
20. Dille BJ, Surowy TK, Gutierrez RA, et al. An ELISA for detection of antibodies to the E2 protein of GB virus C. J Infect Dis 1997;175:458-61.
21. Lara C, Halasz R, Sönnerborg A, et al. Detection of hepatitis G virus RNA in persons with and without known risk factors for blood borne viral infections in Sweden and Honduras. J Clin Microbiol 1998;36:255-7.
22. Tanaka M, Nishiguchi S, Tanaka T, et al. Prevalence of GBV-C and hepatitis G virus variants in patients with fulminant hepatic failure in Japan. J Hepatol 1997;27:966-72.